Hangzhou Tigermed Consulting Co., Ltd
300347
Peringkat dalam Saham
#3217
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Harga Saham
$7.44
Kapitalisasi Pasar
$5.49B
Perubahan (1 hari)
-2.99%
Perubahan (1 tahun)
-0.42%
Negara
CN
Perdagangan Hangzhou Tigermed Consulting Co., Ltd (300347)
Kategori
Healthcare
Margin Operasi untuk Hangzhou Tigermed Consulting Co., Ltd (300347)
Margin Operasi per October 2026 TTM: 16.39%
Menurut laporan keuangan dan harga saham terbaru dari Hangzhou Tigermed Consulting Co., Ltd, margin operasi saat ini (TTM) adalah 16.39%. Pada akhir 2024, margin operasi perusahaan adalah 10.06%.
Riwayat margin operasi untuk Hangzhou Tigermed Consulting Co., Ltd dari 2009 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 16.39% | 10.97% |
| 2025 | 14.77% | 46.82% |
| 2024 | 10.06% | -70.13% |
| 2023 | 33.68% | -7.60% |
| 2022 | 36.45% | -48.60% |
| 2021 | 70.91% | 1.85% |
| 2020 | 69.62% | 79.94% |
| 2019 | 38.69% | 49.38% |
| 2018 | 25.90% | 4.82% |
| 2017 | 24.71% | 45.95% |
| 2016 | 16.93% | -24.18% |
| 2015 | 22.33% | -17.69% |
| 2014 | 27.13% | -10.55% |
| 2013 | 30.33% | 15.59% |
| 2012 | 26.24% | -7.90% |
| 2011 | 28.49% | 1.35% |
| 2010 | 28.11% | 146.80% |
| 2009 | 11.39% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -97.65% |
US
|
|
| -149.01% | -109.09% |
US
|
|
| 25.57% | -98.44% |
AU
|
|
| 31.23% | -98.09% |
BE
|
|
| 28.81% | -98.24% |
NL
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.